
Centre Hospitalier De Tourcoing
- Address
- 155 Rue Du President Coty, Bp 40619
Sponsor Overview
Specializations
Orthopaedic infection and prosthetic joint infection
Clinical research at Centre Hospitalier De Tourcoing includes adult cases of staphylococcal prosthetic joint infection managed with debridement, antibiotics and implant retention (DAIR), with attention to infections involving retained joint prostheses.
- Staphylococcus aureus
- Coagulase-negative staphylococci (CoNS)
- Methicillin-susceptible and methicillin-resistant strains
- Implant retention strategies
The sponsor’s research interest centers on infection control in the setting of retained orthopaedic hardware, with emphasis on staphylococcal pathogens and post-surgical joint infection management.
Antibacterial therapy for device-related infection
Trials supported by the hospital focus on oral treatment options for biofilm-associated infection, particularly comparing rifabutin with rifampicin in the context of prosthetic joint infection.
- Rifabutin
- Rifampicin
- Oral antibiotic therapy
- Biofilm-active treatment
This area reflects a therapeutic interest in antimicrobial options suited to persistent implant-associated infection and long-term management after orthopaedic surgery.
Musculoskeletal surgery and infection management
The clinical research portfolio includes patients treated following debridement and preservation of the prosthetic implant, linking surgical care with targeted antimicrobial treatment in musculoskeletal infection.
- Debridement
- Prosthesis preservation
- Orthopaedic implant infection
- Post-operative infection care
Research interest is concentrated on the clinical setting where surgical source control and antibiotic selection intersect in the treatment of infected joint replacements.
Multicentre infectious disease research
The sponsor participates in collaborative studies involving multiple research sites, supporting clinical investigation in infectious diseases across a broader hospital network.
- Multicentre collaboration
- Adult infectious disease
- Hospital-based research
- Clinical evaluation of antibiotics
This research activity is anchored in hospital care for adults with complex staphylococcal infection requiring coordinated clinical oversight.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Comparison of Rifabutin and Rifampicin in the Management of Staphylococcal Prosthetic Joint Infection Using DAIR Strategy: A Multicenter Randomized Non-Inferiority Trial | France | Recruiting |
Data & Insights
This sponsor works with 2 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 33 sites across their trial portfolio.
Therapeutic Focus
- 1.Bacterial Infections and Mycoses1 trial180 other sponsors
Partnered Research Centres
33 centres- Address
- 264 Rue Saint Pierre, 13005 Marseille
- Address
- 558 Route De Findrol, 74130 74130
- Address
- 27 Rue Delbecque, 62660 Beuvry
- Address
- 39 Avenue De La Liberte, Bp 60535, 68024 Colmar
- Address
- 20 Avenue Du Languedoc, Cs 49954, 66046 Perpignan
- Address
- 155 Rue Du President Coty, Bp 40619, 59208 Tourcoing
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Centre Hospitalier De Tourcoing.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.

